HIV prevention drug could reduce cases globally but USAID cuts prevent access, say experts
People protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. Photograph: Pablo Porciúncula/AFP via Getty ImagesView image in fullscreenPeople protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. PrEP, which also comes in the form of daily oral medications and bimonthly injections, is 99% effective in preventing sexually transmitted HIV for people who take it consistently.In its announcement, the WHO noted that access to lenacapavir is limited outside clinical trials.
- ▪People protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday.
- ▪Photograph: Pablo Porciúncula/AFP via Getty ImagesView image in fullscreenPeople protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday.
- ▪PrEP, which also comes in the form of daily oral medications and bimonthly injections, is 99% effective in preventing sexually transmitted HIV for people who take it consistently.In its announcement, the WHO noted that access to lenacapavir
The Guardian — World publishes from United Kingdom and files mainly under world. We currently carry 2,484 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — World |
| Canonical URL | https://www.theguardian.com/society/2026/jul/31/hiv-aids-medication-usaid-cuts |
| Publication time | Fri, 31 Jul 2026 16:29:14 GMT |
| Retrieval time | 2026-07-31T17:03:28.145Z |
| Last seen | 2026-07-31T17:03:28.145Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | L1vfsaB3vGlO · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
People protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. Photograph: Pablo Porciúncula/AFP via Getty ImagesView image in fullscreenPeople protest against funding cuts and drug patents during the 26th International Aids Conference in Rio de Janeiro on Monday. Photograph: Pablo Porciúncula/AFP via Getty ImagesAids and HIVHIV prevention drug could reduce cases globally but USAID cuts prevent access, say expertsInjectable PrEP drug holds promise but investment in HIV prevention has declined dramatically worldwide Sign up for the Breaking News US newsletter email Hannah Harris Green in Rio de JaneiroFri 31 Jul 2026 12.29 EDTLast modified on Fri 31 Jul 2026 12.54 EDTSharePrefer the Guardian on GoogleNew innovations in HIV…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — World.
Discussion
0 commentsMore from The Guardian — World
